Achieve Life Sciences Inc.

NASDAQ:ACHV  
9.14
+0.07 (+0.77%)
Earnings Announcements

Achieve Life Sciences Reports Q3 2020 Financial Results

Published: 11/12/2020 21:33 GMT
Achieve Life Sciences Inc (ACHV) - Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update.
Achieve Life Sciences Inc - As of September 30, 2020, Co's Cash, Cash Equivalents, and Restricted Cash Was $22.4 Million.
Achieve Life Sciences Inc - Qtrly Loss per Share $1.14.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.80

More details on our Analysts Page.